Atlas Trials

Safety and Efficacy of Multiple Doses of Canakinumab (ACZ885) in Chronic Obstructive Pulmonary Disease (COPD) Patients

Clinical trial NCT00581945 · COMPLETED

Trial details

NCT number
NCT00581945
Sponsor
Novartis
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary Disease
Start date
2007-01-01
Primary completion
2010-05-01
Enrollment
147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.